Prognostic impact of cardiovascular risk factors in patients admitted for acute coronary syndrome

被引:0
|
作者
Puche, J. E. [1 ,2 ]
Iturregui-Guevara, M. [3 ]
Vazquez, R. [1 ]
机构
[1] Hosp Univ Puerta Mar, Serv Cardiol, Cadiz, Spain
[2] Hosp Costa Sol, Serv Dermatol, Marbella, Spain
[3] Hosp Univ Jerez De La Frontera, Serv Endocrinol, Jerez de la Frontera, Spain
来源
HIPERTENSION Y RIESGO VASCULAR | 2023年 / 40卷 / 03期
关键词
Cardiovascular risk factors; Coronavirus; Lockdown; Diabetes; Hypertension; Dyslipidaemia; EUROPEAN-SOCIETY; MYOCARDIAL-INFARCTION; DISEASE PREVENTION; TASK-FORCE; GUIDELINES; CARDIOLOGY; MORTALITY; COUNTRIES;
D O I
10.1016/j.hipert.2022.09.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives: Cardiovascular prevention measures place the emphasis on controlling cardiovascular risk factors (CVRF). However, the most recent studies provide disappointing data, the impact of which remains to be determined. The objective of this study was to analyse the impact that the different CVRFs, and their degree of control, have on the prognosis of patients after acute coronary syndrome.Patients and methods: Epidemiological, pharmacological, and CVRF control data were collected from 1,689 consecutive patients admitted from 2018 to 2020 for acute coronary syndrome to a tertiary hospital. Finally, the rate of major adverse cardiovascular events was calculated. Results: The patients admitted for acute coronary syndrome were predominantly men, with body mass index > 25 Kg/m(2), smokers (or former smokers) and with poor CVRF control (50% for hypertension and diabetes and 35% for dyslipidaemia), especially those patients with a personal history of ischaemic heart disease. An underutilisation of useful drugs for CVRF control was found. A directly proportional relationship was observed between the number of CVRFs (or their poor control) and the incidence of major adverse cardiovascular events at 2 years, hypertension being the factor with the greatest cardiovascular impact. The SARS-CoV-2 lockdown worsened the degree of CVRF control and cardiovascular prognosis.Conclusion: There is still room for improvement in the control of CVRF, which would translate into a prognostic benefit for patients with ischaemic heart disease. The implementation of cardiovascular prevention campaigns seems essential.(c) 2022 SEH-LELHA. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:110 / 118
页数:9
相关论文
共 50 条
  • [21] Acute coronary syndrome in elderly patients - prognostic impact of revascularization
    Arantes, C.
    Abreu, G.
    Martins, J.
    Braga, C.
    Ramos, V.
    Veira, C.
    Azevedo, P.
    Pereira, M. A.
    Rocha, S.
    Correia, A.
    EUROPEAN HEART JOURNAL, 2014, 35 : 314 - 314
  • [22] Prognostic value of telomere length and telomerase polymorphisms in patients admitted for acute coronary syndrome
    Perez Rivera, J. A.
    Pabon Osuna, P.
    Cieza Borrella, C.
    Martin Herrero, F.
    Porras, J. R. Gonzalez
    Duran Bobin, O.
    Valenzuela Vicente, M. C.
    Rama Merchan, J. C.
    Martin Luengo, C.
    Gonzalez Sarmiento, R.
    EUROPEAN HEART JOURNAL, 2013, 34 : 488 - 488
  • [23] The prognostic significance of plasma galectin-3 in patients admitted for acute coronary syndrome
    Malinova, L.
    Podbolotov, R.
    Denisova, T.
    Dovgalevsky, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 421 - 422
  • [24] PROGNOSTIC IMPACT OF RESIDUAL INFLAMMATORY RISK AFTER ACUTE CORONARY SYNDROME
    Toso, A.
    Leoncini, M.
    Villani, S.
    Tropeano, F.
    Maioli, M.
    Bellandi, F.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 (SUPPL C)
  • [25] Association of cardiovascular risk factors with the different presentations of acute coronary syndrome
    Fadini Reis Brunori, Evelise Helena
    Lopes, Camila Takao
    Ruiz Zimmer Cavalcante, Agueda Maria
    Santos, Vinicius Batista
    Lopes, Juliana de Lima
    Bottura Leite de Barros, Alba Lucia
    REVISTA LATINO-AMERICANA DE ENFERMAGEM, 2014, 22 (04): : 538 - 546
  • [26] Acute coronary syndrome in patients without cardiovascular risk factors: in-hospital morbidity and mortality
    Rodrigues Neto, M.
    Correia, A.
    Rodrigues, R.
    Gomes Serrao, M.
    Santos, N.
    Gomes, S.
    Silva, B.
    Caires, G.
    Drumond Freitas, A.
    Pereira, D.
    EUROPEAN HEART JOURNAL, 2015, 36 : 928 - 928
  • [27] Risk Factors for Death or Cardiovascular Events after Acute Coronary Syndrome in Patients with Myeloproliferative Neoplasms
    Leiva, Orly
    Jenkins, Andrew
    Rosovsky, Rachel P.
    Leaf, Rebecca K.
    Goodarzi, Katayoon
    Hobbs, Gabriela
    HEMATOLOGY REPORTS, 2023, 15 (02) : 398 - 404
  • [28] Cardiovascular risk factors among 94,473 acute coronary syndrome patients in Europe
    Kai, S. Huo Yung
    Degano, I. R.
    Malmivaara, A.
    Kirchberger, I.
    Farmakis, D.
    Torre, M.
    Azevedo, A.
    Fusco, D.
    Davoli, M.
    Marrugat, J.
    Ferrieres, J.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1333 - 1333
  • [29] Descriptive and comparative study of cardiovascular risk factors and physical activity in patients with acute coronary syndrome
    Isabel Vazquez-Arce, Maria
    Marques-Sule, Elena
    ATENCION PRIMARIA, 2018, 50 (10): : 576 - 582
  • [30] Prognostic Impact of Coronary Revascularization in Acute Coronary Syndrome Patients With Cardiogenic Shock
    Sakamoto, Kazuo
    Matoba, Tetsuya
    Mohri, Masahiro
    Tanaka, Nobuhiro
    Hokama, Yohei
    Fukutomi, Motoki
    Hashiba, Katsutaka
    Fukuhara, Rei
    Ueki, Yasushi
    Suwa, Satoru
    Matsuura, Hirohide
    Tachibana, Eizo
    Yonemoto, Naohiro
    Nagao, Ken
    CIRCULATION, 2015, 132